1. Biology Department, Science and Engineering faculty, Science and Arts University 2. Biology Department, Faculty of Sciences, Shehrekord University
Breast cancer is a persistent global challenge because of its high prevalence among women (although rarely occurs in men), which is due to its risk factors and it’s gene mutations. to date, breast cancer has undergone many treatments such as surgery, ablation, chemotherapy, radiotherapy, and more specific treatments like hormone therapy and the administration of various substances that reduce cancer’s growth, severity and reappearance.
Precision medicine is a kind of treatment that is relevant to the individual’s needs of each patient, and nowadays it has received a lot of attention due to its importance in the development of effective cancer treatment regimens.
In fact, recent studies have identified a large number of genes and molecules that can be used as biomarkers to predict drug responses and severe symptoms which is associated with breast cancer. these could be good clues not only for the proper selection of appropriate medications and dosages in precision medicine, but also can be useful in identifying target genes or molecules that are involved in the development of breast cancer, which ultimately leads to the promotion of more effective and precise personal therapies for treatment.
In this paper, recent studies could be considered as appropriate options for precision treatment for breast cancer and survivors, that have been reviewed. new methods of optimizing drug and dose selection and identifying genetic changes that are associated with symptoms of cancer can be helpful in increasing of the effectiveness and acceptance of existing treatments for breast cancer.
Precision medicine; breast cancer; treatment; drug dosage